A016790 Stock Overview
CANARIABIO Inc. engages in the manufacture and sale of formulated feed.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CANARIABIO Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩994.00 |
| 52 Week High | ₩14,833.33 |
| 52 Week Low | ₩899.00 |
| Beta | -0.62 |
| 1 Month Change | 0% |
| 3 Month Change | -32.52% |
| 1 Year Change | -92.13% |
| 3 Year Change | -12.55% |
| 5 Year Change | -22.75% |
| Change since IPO | -13.06% |
Recent News & Updates
Shareholder Returns
| A016790 | KR Food | KR Market | |
|---|---|---|---|
| 7D | 0% | 2.9% | -0.4% |
| 1Y | -92.1% | -3.6% | 4.5% |
Return vs Industry: A016790 underperformed the KR Food industry which returned -3.6% over the past year.
Return vs Market: A016790 underperformed the KR Market which returned 4.5% over the past year.
Price Volatility
| A016790 volatility | |
|---|---|
| A016790 Average Weekly Movement | n/a |
| Food Industry Average Movement | 3.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A016790's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine A016790's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 78 | n/a | www.canariabio.com |
CANARIABIO Inc. engages in the manufacture and sale of formulated feed. Its primary products include poultry and pig feed. The company also engages in the biopharmaceutical business.
CANARIABIO Inc. Fundamentals Summary
| A016790 fundamental statistics | |
|---|---|
| Market cap | ₩187.34b |
| Earnings (TTM) | -₩208.33b |
| Revenue (TTM) | ₩160.60b |
1.2x
P/S Ratio-0.9x
P/E RatioIs A016790 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A016790 income statement (TTM) | |
|---|---|
| Revenue | ₩160.60b |
| Cost of Revenue | ₩138.02b |
| Gross Profit | ₩22.58b |
| Other Expenses | ₩230.91b |
| Earnings | -₩208.33b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.11k |
| Gross Margin | 14.06% |
| Net Profit Margin | -129.72% |
| Debt/Equity Ratio | -221.4% |
How did A016790 perform over the long term?
See historical performance and comparison